Noctura 400 - Treating Diabetic Retinopathy in UK Healthcare

Here we provide all the support and information you need in your profession regarding Noctura 400

What is Noctura 400?

Noctura 400 is being used in clinic to treat patients with early stage DMO following the highly successful RENDER study where 96% of patients saw clinical improvement and stabilisation(2).

Across all stages of diabetic eye disease Noctura 400 has demonstrated clinical repair in 66% of patients, and no associated complications(2-6).

Noctura 400 has been used for people with

  • Mild to moderate non-proliferative diabetic retinopathy (1,2)

  • Early, untreated and progressive diabetic macular oedema (2-5)

  • Moderate proliferative diabetic retinopathy (2)

 

Reduced
Retinal Thickness 2,3,5

Fewer
Retinal Cysts 3,4,5

Improved
Visual Acuity 2,5

How to Use Noctura 400

When a patient is prescribed Noctura 400, it isn't just the product - there is a full support team behind them. The Noctura Advisory line is contactable every day from 9-5 with real Noctura 400 experts manning the phones.

There are plenty of online resources that they will be directed to in the first weeks of use. Below is our training video, especially for helping new customers get used to the mask.

Patient Data and Results

Patient A

Before Noctura 400
After 3 months
After 12 Months
3 months mask usage

Patient B

Before Noctura 400
After 3 months
After 12 Months
3 months mask usage

Patient C

Before Noctura 400
After 3 months
After 12 Months
After 12 Months

References

If you would like more information on how to provide Noctura 400 for your patients, contact us.

How to provide Noctura 400 for your patients

Email enquiries@polyphotonix.com
Phone 01740 625 555 (Mon-Fri 9am-5pm)

or

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.